SCHEMBL16136246

SCHEMBL16136246

CC(=O)NCc1[nH]cnc1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
GAA P10253 1/20 0.44
SMO Q99835 1/20 0.43
KMT2A Q03164 3/20 0.41
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
MEN1 O00255 2/20 0.41
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
MGMT P16455 1/20 0.39
ELANE P08246 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19413254 0.85 POLB (0.48) ALDH1A1GAAKMT2AMEN1CYP1A2
SCHEMBL16136333 0.77 KDM4E (0.44) ALDH1A1GAAKMT2AMTNR1AMTNR1B
SCHEMBL8185457 0.76 LTB4R (0.42) ALDH1A1GAATSHRCYP3A4CYP2C9
SCHEMBL16136241 0.76 NPSR1 (0.41) ALDH1A1GAAKMT2AMTNR1AMEN1
SCHEMBL19413253 0.75 TRPA1 (0.39) ALDH1A1GAAKMT2AMEN1TSHR
Hydrochloric Acid SCHEMBL11315877 0.74 LTB4R (0.41) ALDH1A1GAATSHRCYP3A4CYP2C9
SCHEMBL97001 0.71 KMT2A (0.68) ALDH1A1GAAKMT2AMEN1TSHR
SCHEMBL16136348 0.70 MGMT (0.39) ALDH1A1KMT2AMTNR1AMTNR1BCYP1A2
Acetic Acid SCHEMBL10568555 0.69 KMT2A (0.66) ALDH1A1GAAKMT2AMEN1TSHR
Bromide SCHEMBL30703423 0.69 KMT2A (0.66) ALDH1A1GAAKMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776996-B2 Substituted 6,5-fused bicyclic heteroaryl compounds Epizyme, Inc. (US) 2017-10-03 US disclosed
US-20160326170-A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Epizyme, Inc. 2016-11-10 US disclosed
US-9365570-B2 Substituted 6, 5-fused bicyclic heteroaryl compounds Epizyme, Inc. (US) 2016-06-14 US disclosed
US-20160024081-A1 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds Epizyme, Inc. 2016-01-28 US disclosed
US-20150246916-A1 Substituted 6, 5-Fused Bicyclic Heteroaryl Compounds Epizyme, Inc. 2015-09-03 US disclosed
US-9045477-B2 Substituted 6,5-fused bicyclic heteroaryl compounds Epizyme, Inc. (US) 2015-06-02 US disclosed
US-20140296283-A1 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds Epizyme, Inc. (US) 2014-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024081-A1 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds CYP3A5, PAICS, CYP4B1 ALDH1A1 594/4885GAA 969/4885SMO 1462/4885
US-20150246916-A1 Substituted 6, 5-Fused Bicyclic Heteroaryl Compounds CYP3A5, PAICS, CYP4B1 ALDH1A1 594/4885GAA 969/4885SMO 1462/4885
US-20140296283-A1 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds CYP3A5, PAICS, CYP4B1 ALDH1A1 594/4885GAA 969/4885SMO 1462/4885
US-20160326170-A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS CYP3A5, PAICS, CYP4B1 ALDH1A1 594/4885GAA 969/4885SMO 1462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.